UBS Group AG UBS
49.67
1.21
2.50%
as of 25 Sep
- Market cap
- $149.9B
- P/E
- 16.2×
Follow UBS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 10.63% | 10.12% | 8.82% | 8.25% |
+8 more TTM periods Free account |
|
| 0.56% | 1.18% | 0.49% | 0.45% | ||
ROIC |
3.60% | 0.00% | 0.00% | 3.20% | |
Return on Tangible Assets |
8.18% | (8.60%) | 2.84% | 6.98% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
3.84 | 0.00 | 6.25 | 0.70 | |
Free Cash Flow |
11,828.00 | — | 19,698.00 | 2,215.00 | |
Capital Expenditures |
(2,700.00) | — | (2,153.00) | (2,079.00) | |
Piotroski F-Score |
6.00 | — | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
2.08% | 0.00% | 2.59% | 0.63% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.03 | 0.03 | 0.04 | |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 11,319.51 | 10,840.23 | 10,125.29 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.20) | (0.13) | (0.12) | (0.10) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
54.49% | 48.69% | 48.86% | 48.13% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.53 | 0.00 | 2.81 | 0.59 | |
Depreciation/Fixed assets |
0.26 | 0.00 | 0.22 | 0.23 | |
Capex/Depreciation |
(0.64) | — | (0.61) | (0.57) | |
Revenue per Share |
22.36 | 24.76 | 24.15 | 24.58 | |
Operating CF per Share |
4.71 | 0.00 | 6.93 | 1.37 | |
Capex per Share |
(0.88) | 0.00 | (0.68) | (0.66) | |
Capex to Sales |
0.04 | 0.00 | 0.03 | 0.03 | |
Net Profit Margin |
13.80% | 11.90% | 10.20% | 9.49% |
Columns are period end dates